Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2022-11-20
2023-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: what was the impact of the urinary artificial sphincter on the global management of the patient.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bladder Neck Surgery in Children With Neurogenic Bladder
NCT05861011
Complications of Bladder Augmentation in Children
NCT06733194
Applicability of Uroflowmetry in Children with Cerebral Palsy
NCT05017415
Complications of Enterocystoplasty in Children
NCT05840874
Fetal Cystoscopy for Lower Urinary Tract Obstruction
NCT02446184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators want to analyse the participants data, that led to indication of an urinary artificial sphincter, and its outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urinary Artificial Sphincter (UAS) in Children
Patients aged under 18 years old with UAS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lorraine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Christelle DESTINVAL
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christelle Destinval, MD
Role: PRINCIPAL_INVESTIGATOR
University of Lorraine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ULorraine
Vandœuvre-lès-Nancy, Grand Est, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Delgado-Miguel C, Munoz-Serrano A, Amesty V, Rivas S, Lobato R, Martinez-Urrutia MJ, Lopez-Pereira P. Artificial urinary sphincter in congenital neuropathic bladder: Very long-term outcomes. Int J Urol. 2022 Jul;29(7):692-697. doi: 10.1111/iju.14874. Epub 2022 Mar 26.
Sheppard KE, Roberts JL, Blum M. Adrenocorticotropin-releasing factor down-regulates glucocorticoid receptor expression in mouse corticotrope tumor cells via an adenylate cyclase-dependent mechanism. Endocrinology. 1991 Aug;129(2):663-70. doi: 10.1210/endo-129-2-663.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023PI008
Identifier Type: REGISTRY
Identifier Source: secondary_id
ULorr
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.